Prophylactic Anti-Cytomegalovirus Hyperimmunoglobulin in Critically Ill Liver Transplant Patients: Impact on Early Immunology and Survival

Background: Anti-cytomegalovirus hyperimmunoglobulin (CMVIg) was shown to provide beneficial immunodulatory properties beyond antiviral efficacies. The aim of this retrospective study was to assess the impact of prophylactic CMVIg treatment on early outcome following liver transplantation (LT) in cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kornberg, Arno, Witt, Ulrike, Kornberg, Jennifer, Müller, Katharina, Friess, Helmut, Thrum, Katharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141244/
https://www.ncbi.nlm.nih.gov/pubmed/32121313
http://dx.doi.org/10.3390/jcm9030656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141244/
https://www.ncbi.nlm.nih.gov/pubmed/32121313
http://dx.doi.org/10.3390/jcm9030656

Ejemplares similares